Epigenetic Therapy Promotes the Ratio of Th1/Th17 Lineage to Reverse Immune Evasion and Treat Leukemia Relapse Post-allogeneic Stem Cell Transplantation in Non-APL AML Patients

To reverse the early-stage relapse post-hematopoietic stem cell transplantation, we investigated the safety and efficacy of a new epigenetic regimen (chidamide and decitabine plus thymalfasin simultaneously) on acute myeloid leukemia patients (excluding acute promyelocytic leukemia). Twenty-four pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, Yang, Jingying, Dai, Chenglong, Li, Hong, Zheng, Rong, Zhang, Xiaodong, Wang, Chunsen, Wang, Xiaobing, Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421566/
https://www.ncbi.nlm.nih.gov/pubmed/34504867
http://dx.doi.org/10.3389/fmolb.2020.595395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421566/
https://www.ncbi.nlm.nih.gov/pubmed/34504867
http://dx.doi.org/10.3389/fmolb.2020.595395

Ejemplares similares